We found that the levels of CD8+ T cells, neutrophils, tumour-infiltrating lymphocytes (TILs), cytokine activity, HLA, inflammation promotion, MHC class I, and the type I IFN response were high in our samples (Figure 3). The gene discussed is CD8A; the disease is neoplasm.